NCT02843646

Brief Summary

The purpose of this study is to investigate the use of the WalkAide, a Neuroprosthetic device, on a child's ability to ascend/descend stairs and curbs. It is hypothesized that with WalkAide use, the improved ankle control achieved, will affect the speed, symmetry, and independence of completing the task.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

July 19, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 26, 2016

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

January 10, 2022

Status Verified

January 1, 2022

Enrollment Period

7 years

First QC Date

July 19, 2016

Last Update Submit

January 5, 2022

Conditions

Keywords

gait trainingstepping

Outcome Measures

Primary Outcomes (2)

  • Change in the Timed-Up-and-Down-Stairs (TUDS) measure

    Measures the ability of a child to negotiate stairs

    Day 1 of intervention and up to 5 days after the last day of intervention

  • Change in the Step-Up-and-Over measure

    Measures the ability of a child to step up and over a curb

    Day 1 of intervention up to 5 days after the last day of intervention

Secondary Outcomes (1)

  • Pain scale

    Each day of therapy, from date of randomization until up to six weeks after date of randomization

Study Arms (2)

Walk Aide training

EXPERIMENTAL

This group of children will receive six weeks of Walk Aide training. During training, children will wear the Walk Aide. This device triggers ankle dorsiflexion, and controls the timing and duration of personal nerve stimulation during the swing phase of gait. The duration of the stimulus is gradually increased along with the wearing of the Walkaide. Subjects will begin by wearing the prosthesis for 30 minutes. The wearing time will be increased to waking hours of the subject, depending on their age. The electrodes will be placed on the client before the session is to begin, and taken off immediately after WalkAide usage. The skin will be checked before and after WalkAide electrode usage. The skin will be cleaned with an alcohol wipe before the electrodes are applied.

Device: Walk Aide training

Delayed Walk Aide training

PLACEBO COMPARATOR

This group of children will not receive Walk Aide training during the first six weeks of enrollment. This group will serve as a comparator group to Arm 1. After six weeks, children in this group will be given the option to complete the 6-week Walk Aide training protocol that is given in Arm 1.

Device: Walk Aide training

Interventions

Delayed Walk Aide trainingWalk Aide training

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Ability to ambulate independently with or without an assistive device and/or lower extremity orthoses.
  • Ability to follow and understand experimental procedures.

You may not qualify if:

  • Seizure history interfering with use of functional electrical stimulation as verified by their MD.
  • Inability to be able to complete the assessment tests to gain a baseline score.
  • Skin irritation/skin intact.
  • Uncorrected vision impairments.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Blythedale Children's Hospital

Valhalla, New York, 10595, United States

RECRUITING

MeSH Terms

Conditions

Cerebral PalsyGait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 19, 2016

First Posted

July 26, 2016

Study Start

July 1, 2016

Primary Completion

July 1, 2023

Study Completion

July 1, 2023

Last Updated

January 10, 2022

Record last verified: 2022-01

Locations